Market Movers

China Tower’s Stock Price Climbs to 1.00 HKD, Marks Positive Move with 1.01% Growth

China Tower (788)

1.00 HKD +0.01 (+1.01%) Volume: 227.51M

China Tower’s stock price stands at 1.00 HKD, witnessing a positive change of +1.01% this trading session with a high trading volume of 227.51M. The stock has shown robust performance with a year-to-date gain of +21.95%, indicating a strong market presence and growth.


Latest developments on China Tower

Today, China Tower (00788) experienced a bearish block trade with 2.3 million shares being sold at $1.0, resulting in a turnover of $2.3 million. This event has had a noticeable impact on the stock price movement of China Tower. Investors are closely monitoring these developments as they assess the implications for the company’s performance in the market.


A look at China Tower Smart Scores

FactorScoreMagnitude
Value5
Dividend5
Growth4
Resilience2
Momentum5
OVERALL SMART SCORE4.2

Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma

China Tower Corporation Limited, a telecommunication company operating in China, has received high scores across various factors indicating a positive outlook for the company. With top scores in Value and Dividend, investors can expect strong returns and consistent payouts. Additionally, the company has scored well in Growth and Momentum, suggesting potential for expansion and market performance. However, its lower score in Resilience may indicate some vulnerability to market fluctuations.

China Tower’s focus on telecommunication towers construction, maintenance, and ancillary facilities management positions it as a key player in the industry. With a strong emphasis on value and dividends, coupled with growth and momentum, the company appears to be well-positioned for long-term success in the telecommunications sector within China.


Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.


 

πŸ’‘ Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • βœ“ Unlimited Research Summaries
  • βœ“ Personalised Alerts
  • βœ“ Custom Watchlists
  • βœ“ Company Analytics and News
  • βœ“ Events & Webinars